Literature DB >> 32795610

Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut-Brain Axis.

Melinda A Engevik1, Berkley Luck1, Chonnikant Visuthranukul2, Faith D Ihekweazu3, Amy C Engevik4, Zhongcheng Shi1, Heather A Danhof5, Alexandra L Chang-Graham5, Anne Hall6, Bradley T Endres7, Sigmund J Haidacher1, Thomas D Horvath1, Anthony M Haag1, Sridevi Devaraj1, Kevin W Garey7, Robert A Britton5, Joseph M Hyser5, Noah F Shroyer8, James Versalovic9.   

Abstract

BACKGROUND & AIMS: The human gut microbiota can regulate production of serotonin (5-hydroxytryptamine [5-HT]) from enterochromaffin cells. However, the mechanisms underlying microbial-induced serotonin signaling are not well understood.
METHODS: Adult germ-free mice were treated with sterile media, live Bifidobacterium dentium, heat-killed B dentium, or live Bacteroides ovatus. Mouse and human enteroids were used to assess the effects of B dentium metabolites on 5-HT release from enterochromaffin cells. In vitro and in vivo short-chain fatty acids and 5-HT levels were assessed by mass spectrometry. Expression of tryptophan hydroxylase, short-chain fatty acid receptor free fatty acid receptor 2, 5-HT receptors, and the 5-HT re-uptake transporter (serotonin transporter) were assessed by quantitative polymerase chain reaction and immunostaining. RNA in situ hybridization assessed 5-HT-receptor expression in the brain, and 5-HT-receptor-dependent behavior was evaluated using the marble burying test.
RESULTS: B dentium mono-associated mice showed increased fecal acetate. This finding corresponded with increased intestinal 5-HT concentrations and increased expression of 5-HT receptors 2a, 4, and serotonin transporter. These effects were absent in B ovatus-treated mice. Application of acetate and B dentium-secreted products stimulated 5-HT release in mouse and human enteroids. In situ hybridization of brain tissue also showed significantly increased hippocampal expression of 5-HT-receptor 2a in B dentium-treated mice relative to germ-free controls. Functionally, B dentium colonization normalized species-typical repetitive and anxiety-like behaviors previously shown to be linked to 5-HT-receptor 2a.
CONCLUSIONS: These data suggest that B dentium, and the bacterial metabolite acetate, are capable of regulating key components of the serotonergic system in multiple host tissues, and are associated with a functional change in adult behavior.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bifidobacterium; Enterochromaffin Cells; Enteroids; Free Fatty Acid Receptor (FFAR)2; Organoids; Probiotics; Serotonin; Serotonin Transporter; Short-Chain Fatty Acids (SCFAs)

Mesh:

Substances:

Year:  2020        PMID: 32795610      PMCID: PMC7683275          DOI: 10.1016/j.jcmgh.2020.08.002

Source DB:  PubMed          Journal:  Cell Mol Gastroenterol Hepatol        ISSN: 2352-345X


By using gnotobiotic mice, and mouse and human intestinal enteroids, we found that Bifidobacterium dentium–produced acetate stimulates 5-hydroxytryptamine production from enterochromaffin cells. In addition, we show that B dentium modulates 5-hydroxytryptamine–receptor expression in the gut and brain and modifies behavior. The gastrointestinal (GI) tract supports a rich microbial community capable of modulating the host.1, 2, 3 Recent work has identified an essential role for a complex microbiota in regulation of host-derived serotonin (5-hydroxytryptamine [5-HT]). Intestinal enterochromaffin cells synthesize the majority of the body’s 5-HT via the enzyme tryptophan hydroxylase-1 (TTHP-1).4, 5, 6 Enterochromaffin cell stimulation releases the stored 5-HT,,7, 8, 9 which can activate up to 14 different intestinal and neuronal 5-HT–receptor subtypes.10, 11, 12, 13 5-HT can stimulate a number of targets in the GI tract, while also modulating the gut–brain axis to affect both anxiety-like and repetitive or impulsive behaviors.14, 15, 16 Evidence from studies using germ-free mice have suggested that a lack of gut microbiota causes impaired 5-HT signaling. In comparison with specific pathogen-free (SPF) mice with an intact microbiota, germ-free mice have altered 5-HT concentrations and turnover in the brain, decreased levels of circulating 5-HT and its precursor L-tryptophan, and decreased cecal and fecal 5-HT.,17, 18, 19, 20, 21 Germ-free mice also show aberrant behavior including reduced anxiety-like behaviors, diminished repetitive behaviors, and decreased cognitive function relative to mice with a complete gut microbiota.22, 23, 24 Because 5-HT has been implicated in a variety of emotional, cognitive, and behavioral control processes,14, 15, 16 the observed 5-HT deficiency in germ-free mice may help explain these behaviors. Together, the evidence suggests that a lack of a gut microbiota impacts 5-HT pathways and complex behaviors. Studies have shown that gut microbiota modulate the GI serotonergic system; although the specific bacterial species and mechanisms of regulation remain unclear. Addition of human gut microbiota to germ-free mice increases Tph-1 expression and colonic 5-HT concentrations. Moreover, addition of spore-forming microbes from healthy mice and humans to germ-free mice promotes 5-HT biosynthesis by colonic enterochromaffin cells, resulting in increased serum 5-HT concentrations. Human gut microbes do not appear to synthesize 5-HT, indicating that bacterial stimulation of mammalian 5-HT secretion is pivotal in governing 5-HT biochemistry in the host. These previous studies,, provide strong evidence for microbial regulation of 5-HT. However, previously published work has described the effects of complex microbial communities, rather than defined bacterial species, in a gnotobiotic host. It remains to be elucidated which bacterial species stimulate 5-HT production, and the molecular pathways of microbial-induced serotonin signaling between the gut and central nervous system. 5-HT secretion is influenced by microbial-produced short-chain fatty acids (SCFAs), which are sensed by G-protein–coupled receptors 40 and 43, also known as free fatty acid receptor 2 and 3 (FFAR2 and FFAR3).26, 27, 28, 29, 30, 31, 32, 33 Acetate is the most abundant colonic SCFA and is known to preferentially signal through FFAR2.,, Luminal stimulation of FFAR2 with the agonist phenylacetamide-1 in rat intestinal loops stimulates 5-HT release., Moreover, exposure of mouse intestinal enteroids to acetate stimulates 5-HT release, indicating a functional link between SCFAs and 5-HT. Commensal Bifidobacterium species include a number of acetate-producing taxa,37, 38, 39, 40 which have been shown to protect mice from a lethal infection with enterohemorrhagic Escherichia coli O157:H7, and is important for microbial cross-talk. Bifidobacterium dentium is an acetate-producing colonizer of the healthy adult GI tract, and has been reported to modulate sensory neuronal activity in a rat fecal retention model of visceral hypersensitivity. Thus, we reasoned that B dentium would be an ideal choice to address the question of whether specific commensal bacteria alter in vivo acetate concentrations and modulate the serotonergic system in mammals. In this study, we show that B dentium–produced metabolites stimulate 5-HT release from enterochromaffin cells both in vitro and in vivo. We observed that B dentium–colonized mice showed increased intestinal acetate and increased 5-HT concentrations in the intestinal lumen. These effects were not observed in mice treated with heat-killed B dentium or mono-associated with another commensal microbe: Bacteroides ovatus. B dentium mono-association also altered the expression of several key intestinal serotonin receptors, particularly isoforms 2a (Htr2a), and 4 (Htr4), and the 5-HT transporter, serotonin transporter (Sert), compared with germ-free controls. In addition, B dentium–colonized mice up-regulated expression of Htr2a in the hippocampus and colonization normalized the anxiolytic behavior observed in germ-free mice during the marble bury test. Together, these data show that B dentium can modulate serotonin-receptor–mediated signaling in the gut and brain of a gnotobiotic mammal.

Results

B dentium Colonizes the Adult Germ-Free Mouse Intestine

Adult Swiss Webster germ-free mice were divided into 2 groups, splitting mice from the same litters evenly. Both male and female mice were tested to account for possible sex-dependent effects. The mice were housed in separate isolators and were orally gavaged with B dentium on days 1, 3, 5, and 14 of the experiment to promote colonization. The B dentium treatment consisted of 2 × 108 viable B dentium cells in 200 μL MRS bacterial culture media, resulting in colonization of the mice after day 1 of treatment. As a control, germ-free mice were gavaged with 200 μL sterile MRS media or heat-killed B dentium. B dentium mono-association and verification of germ-free status was tracked via tissue staining, FISH, qPCR, conventional plating, and scanning electron microscopy (Figure 1). To assess the regions of B dentium colonization, sections of ileum and colon were examined by tissue Gram staining (Figure 1A). Compared with germ-free controls, B dentium mono-associated mice showed colonization of the mucus layer of the ileum, with increasing abundance observed in the colon. In contrast, only a few heat-killed B dentium were observable in the colon. This finding was confirmed further by FISH using a Bifidobacterium genus-specific probe (Bif164) in germ-free and live B dentium mono-associated mice colon (Figure 1B).
Figure 1

(A) Representative images of tissue Gram stain showing colonization of the ileum and colon in B dentium–colonized mice (n = 20) and the absence of bacterial cells in germ-free mice (n = 20). Sparse y-shaped Bifidobacteria cells were observed in heat-killed B dentium–treated mice (n = 10). Scale bar: 50 μm. (B) Representative images of FISH of colon tissue probed with Bifidobacterium genus–specific probe (Bif164) in both germ-free and B dentium–colonized mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 50 μm. (C) Quantitative results of B dentium colonization as measured by both qPCR and conventional agar plating of feces from colonized mice. (D) Representative scanning electron micrographs of B dentium (falsely colored in purple) adhering to human colonic mucin-producing LS174 cells (n = 3 replicates, 3 independent experiments). Scale bar: 5 μm. (E) Representative scanning electron micrographs of B dentium (falsely colored in purple) in B dentium mono-associated mouse colon (n = 3 per group). Scale bar: 20 μm. (F) Mouse weight in grams at day 17 (germ-free: n = 20 males, n = 20 females; live B dentium: n = 20 males, n = 20 females; and heat-killed B dentium: n = 6 males, n = 6 females). Analysis of (G) villus height in the ileum and (H) crypt depth in the colon of treated mice (germ-free: n = 5 males, n = 5 females; live B dentium: n = 5 males, n = 5 females; and heat-killed B dentium: n = 5 males, n = 5 females). Bd, B dentium.

(A) Representative images of tissue Gram stain showing colonization of the ileum and colon in B dentium–colonized mice (n = 20) and the absence of bacterial cells in germ-free mice (n = 20). Sparse y-shaped Bifidobacteria cells were observed in heat-killed B dentium–treated mice (n = 10). Scale bar: 50 μm. (B) Representative images of FISH of colon tissue probed with Bifidobacterium genus–specific probe (Bif164) in both germ-free and B dentium–colonized mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 50 μm. (C) Quantitative results of B dentium colonization as measured by both qPCR and conventional agar plating of feces from colonized mice. (D) Representative scanning electron micrographs of B dentium (falsely colored in purple) adhering to human colonic mucin-producing LS174 cells (n = 3 replicates, 3 independent experiments). Scale bar: 5 μm. (E) Representative scanning electron micrographs of B dentium (falsely colored in purple) in B dentium mono-associated mouse colon (n = 3 per group). Scale bar: 20 μm. (F) Mouse weight in grams at day 17 (germ-free: n = 20 males, n = 20 females; live B dentium: n = 20 males, n = 20 females; and heat-killed B dentium: n = 6 males, n = 6 females). Analysis of (G) villus height in the ileum and (H) crypt depth in the colon of treated mice (germ-free: n = 5 males, n = 5 females; live B dentium: n = 5 males, n = 5 females; and heat-killed B dentium: n = 5 males, n = 5 females). Bd, B dentium. To confirm colonization, fresh fecal pellets were collected throughout the 2-week oral gavage period. Conventional agar plating and quantitative PCR analysis of genomic DNA extracted from feces confirmed B dentium colonization (Figure 1C). Approximately 1 × 108 CFU of B dentium was observed per gram of mouse feces (Figure 1C). No growth was observed in germ-free or heat-killed B dentium–treated mouse stool. To confirm that B dentium was able to adhere to intestinal cells, the human mucus-producing colonic cell line LS174T was incubated with B dentium for 1 hour, thoroughly washed, and then examined by scanning electron microscopy. B dentium was localized near the surface of these mucus-producing cells (Figure 1D). This finding correlated well with scanning electron microscopy analysis of tissue from B dentium mono-associated mice, where bacteria were found above the epithelium (Figure 1E). We also assessed the weight of the mice upon exiting the isolators (Figure 1F) and observed no significant differences between groups. In addition, we measured villus height in the ileum and crypt depth in the colons of germ-free and treated mice and also observed no differences (Figure 1G and H). Likewise, no changes were observed in the lengths of either the small or large intestine (data not shown). Taken together, these data show that B dentium successfully colonizes the mouse intestine, but does not influence weight or intestinal morphology.

B dentium Mono-associated Mice Have Increased Intestinal Acetate and 5-HT Concentrations

Consistent with genome annotation and predicted functional SCFA output (KEGG map 01120; EC1.8.1.4), B dentium was found to produce 1549.6 μM acetate in LDM4 in vitro. These findings were reflected in vivo as B dentium mono-associated mice showed significantly increased acetate concentrations in their feces compared with germ-free controls. No other significant differences were found among the other SCFAs tested (Figure 2A).
Figure 2

dentium mono-associated mice harbor increased acetate concentrations and colonic expression of the acetate receptor FFAR2. (A and B) Bars show variation in SCFA concentrations (ng/mL) in feces of germ-free and live B dentium mono-associated mice (n = 5/group). (B) Representative enlarged image of enterochromaffin cells from a germ-free mouse, showing co-expression of FFAR2 on 5-HT–positive cells within the intestine. (C) Representative images of ileum and colon tissue from germ-free, live B dentium mono-associated and heat-killed B dentium–treated mice stained with an anti-FFAR2 antibody. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Inset shows the classic enteroendocrine cell shape of FFAR2-positive cells, outlined in white. Scale bar: 100 μm. (D) Quantification of the number of FFAR2-positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (E) Relative fold change in ileal and colonic expression of the FFAR2 gene in germ-free, live B dentium mono-associated or heat-killed B dentium mice as measured by qPCR (n = 10/group). All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001, ∗∗∗∗P < .0001. Bd, B dentium.

dentium mono-associated mice harbor increased acetate concentrations and colonic expression of the acetate receptor FFAR2. (A and B) Bars show variation in SCFA concentrations (ng/mL) in feces of germ-free and live B dentium mono-associated mice (n = 5/group). (B) Representative enlarged image of enterochromaffin cells from a germ-free mouse, showing co-expression of FFAR2 on 5-HT–positive cells within the intestine. (C) Representative images of ileum and colon tissue from germ-free, live B dentium mono-associated and heat-killed B dentium–treated mice stained with an anti-FFAR2 antibody. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Inset shows the classic enteroendocrine cell shape of FFAR2-positive cells, outlined in white. Scale bar: 100 μm. (D) Quantification of the number of FFAR2-positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (E) Relative fold change in ileal and colonic expression of the FFAR2 gene in germ-free, live B dentium mono-associated or heat-killed B dentium mice as measured by qPCR (n = 10/group). All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001, ∗∗∗∗P < .0001. Bd, B dentium. The intestinal epithelium is composed of a heterogenous collection of specialized cells that perform various functions in health and disease. One important cell type is the enterochromaffin cell, an enteroendocrine cell subtype, which has been shown to play a key role in serotonergic signaling.,,73, 74, 75 Enterochromaffin cells contribute to intestinal homeostasis through sensing and responding to signals from the intestinal environment. One important component contributing to enterochromaffin cell responses to SCFAs is the G-protein–coupled receptor FFAR2.,,,,, We established that the FFAR2 receptor was expressed in select subsets of 5-HT–positive cells in our germ-free mice (Figure 2B), suggesting that SCFA-mediated processes, such as 5-HT release, may be occurring in vivo. Immunostaining showed no changes in ileal FFAR2 between germ-free, live, B dentium–treated, or heat-killed B dentium–treated mice (Figure 2C and D). However, we did observe increased colonic FFAR2 staining in enterocytes and enteroendocrine cells in live B dentium–treated mice compared with germ-free or heat-killed B dentium–treated controls. This increase in staining was reflected in the level of Ffar2 mRNA in the colon (Figure 2E). These data suggest that FFAR2 may be able to mediate some B dentium signals in enteroendocrine cells. We postulated that FFARs may stimulate 5-HT release in response to microbial-produced acetate. To address this question, we first determined that B dentium does not contain the gene pathway for the production of 5-HT (KEGG), and we confirmed that 5-HT was not detectable in bacterial media inoculated with B dentium (data not shown). To determine the functional impact of B dentium colonization on enterochromaffin-produced serotonin, we assessed 5-HT concentrations by immunostaining, qPCR, and LC-MS/MS. Increased numbers of 5-HT–positive cells were observed in both the ileum and colon of B dentium mono-associated mice relative to germ-free and heat-killed B dentium–treated mice (Figure 3A and B). Increases in 5-HT were observed in enteroendocrine cells directly above enteric neurons (Figure 3C). TPH-1 is the rate limiting enzyme for 5-HT production in enterochromaffin cells. The results of the immunostaining were corroborated by the significant increase in Tph-1 expression in both the ileum and colon of B dentium mono-associated mice relative to germ-free and heat-killed B dentium–treated mice (Figure 3D). Increased Tph-1 gene expression also was accompanied by significantly increased 5-HT concentrations in the intestinal lumen of mice, as measured by LC-MS/MS (Figure 3E). Other groups have found that colonization by a complex gut microbiota increases the number of 5-HT–positive cells, without changing the total number of enterochromaffin cells. To examine the distribution of enterochromaffin cells within our model, we examined the levels of chromogranin A (ChgA), the gold standard for identification of enterochromaffin cells, by qPCR (Figure 3F) and immunostaining quantification (Figure 3G). In our model, no significant changes were observed in enterochromaffin expression or cell numbers between groups. However, we did observe increased numbers of 5-HT–positive ChgA-positive enterochromaffin cells (Figure 3H). Taken together, these results indicate that B dentium colonization increases the number of 5-HT–positive enterochromaffin cells and increases intestinal 5-HT.
Figure 3

(A) Representative images of ileum and colon tissue stained with an anti–5-HT antibody showing both increased staining intensity in enterochromaffin cells in B dentium mono-associated mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Inset shows the classic enterochromaffin cell shape of 5-HT–positive cells, outlined in white. Scale bar: 100 μm. (B) Quantification of the number of 5-HT–positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (C) Representative image of 5-HT–positive enterochromaffin cell in close proximity to a CHAT-stained enteric neuron in a live B dentium–treated mouse ileum. Scale bar: 10 μm. (D) Relative fold changes in expression of Thp-1 in the ileum and colon of germ-free, live B dentium mono-associated and heat-killed B dentium mice (n = 10/group). (E) Serotonin concentrations (ng/mL) in the lumen of the ileum and colon (n = 10/group) as measured via mass spectrometry. (F) Relative fold change in expression of ChgA in ileal and colonic tissue in germ-free, live, B dentium mono-associated and heat-killed B dentium–treated mice (n = 10/group) as measured via qPCR. (G) Quantification of the number of ChgA-positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (H) Quantification of the number of cells that co-stain for 5-HT and ChgA (5-HT–positive/ChgA-positive cells) identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. CHAT, choline acetyltransferase; EC, enterochromaffin cell.

(A) Representative images of ileum and colon tissue stained with an anti–5-HT antibody showing both increased staining intensity in enterochromaffin cells in B dentium mono-associated mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Inset shows the classic enterochromaffin cell shape of 5-HT–positive cells, outlined in white. Scale bar: 100 μm. (B) Quantification of the number of 5-HT–positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (C) Representative image of 5-HT–positive enterochromaffin cell in close proximity to a CHAT-stained enteric neuron in a live B dentium–treated mouse ileum. Scale bar: 10 μm. (D) Relative fold changes in expression of Thp-1 in the ileum and colon of germ-free, live B dentium mono-associated and heat-killed B dentium mice (n = 10/group). (E) Serotonin concentrations (ng/mL) in the lumen of the ileum and colon (n = 10/group) as measured via mass spectrometry. (F) Relative fold change in expression of ChgA in ileal and colonic tissue in germ-free, live, B dentium mono-associated and heat-killed B dentium–treated mice (n = 10/group) as measured via qPCR. (G) Quantification of the number of ChgA-positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (H) Quantification of the number of cells that co-stain for 5-HT and ChgA (5-HT–positive/ChgA-positive cells) identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. CHAT, choline acetyltransferase; EC, enterochromaffin cell.

Not All Commensal Microbes Promote Serotonin Production

To confirm that modulation of serotonin was not a ubiquitous feature of gut microbes, we mono-associated mice with another commensal microbe, B ovatus. Previous studies have found that mono-association with Bacteroides thetaiotaomicron did not influence serotonin. Thus, we predicted that mono-association of a closely related Bacteroides would confirm that not all microbes modulate intestinal serotonin. Colonization of germ-free mice with B ovatus was confirmed by PCR with a B ovatus–specific primer and BHI agar plating. Interestingly, we observed no changes in 5-HT by immunostaining and quantification in the ileum or colon of B ovatus mono-associated mice compared with germ-free controls (Figure 4A and B). We also found no changes in Tph-1 or serotonin levels between groups (Figure 4C and D). LC-MS/MS analysis showed that B ovatus mono-associated stool harbored 4 times lower concentrations of acetate (8.7 ± 7.0 μM) than B dentium mono-associated stool (33.0 ± 16.6 μM) (Figure 4E). However, moderate levels of propionate (15.2 ± 2.6 μM) were observed in B ovatus–treated stool. No changes were observed in other SCFAs. This is consistent with the KEGG pathway for B ovatus, which indicates that B ovatus has the genes to produce acetate (EC1.8.1.4) and propionate (EC2.7.2.1) (KEGG). Consistent with our B dentium mono-associated mice, we saw no change in ChgA expression or the number of enterochromaffin cells quantified from immunostaining in B ovatus–treated mice compared with germ-free controls (Figure 4F and G). As a result, the number of 5-HT–positive ChgA-positive cells were the same between B ovatus and germ-free groups (Figure 4H). These findings suggest that not all bacteria are able to promote serotonin production in vivo.
Figure 4

(A) Representative images of ileum and colon tissue stained with an anti–5-HT antibody in germ-free and B ovatus mono-associated mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Insets show the classic enterochromaffin cell shape of 5-HT–positive cells (white outline). Scale bar: 100 μm. (B) Quantification of the number of 5-HT–positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (C) Relative fold changes in expression of Thp-1 in the ileum and colon of germ-free or live B ovatus mice (n = 10/group). (D) Serotonin concentrations (ng/mL) in the lumen of the ileum and colon (n = 10/group) as measured via mass spectrometry. (E) SCFA LC-MS/MS analysis of germ-free, live B dentium and live B ovatus–treated mouse stool. (F) Relative fold change in expression of ChgA in ileal and colonic tissue in germ-free or live B ovatus mono-associated mice (n = 10/group) as measured via qPCR. (G) Quantification of the number of ChgA-positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (H) Quantification of the number of cells that co-stain for 5-HT and ChgA (5-HT–positive/ChgA-positive cells) identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). All data are presented as means ± SD. ∗∗∗∗P < .0001. EC, enterochromaffin cell.

(A) Representative images of ileum and colon tissue stained with an anti–5-HT antibody in germ-free and B ovatus mono-associated mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Insets show the classic enterochromaffin cell shape of 5-HT–positive cells (white outline). Scale bar: 100 μm. (B) Quantification of the number of 5-HT–positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (C) Relative fold changes in expression of Thp-1 in the ileum and colon of germ-free or live B ovatus mice (n = 10/group). (D) Serotonin concentrations (ng/mL) in the lumen of the ileum and colon (n = 10/group) as measured via mass spectrometry. (E) SCFA LC-MS/MS analysis of germ-free, live B dentium and live B ovatus–treated mouse stool. (F) Relative fold change in expression of ChgA in ileal and colonic tissue in germ-free or live B ovatus mono-associated mice (n = 10/group) as measured via qPCR. (G) Quantification of the number of ChgA-positive cells identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). (H) Quantification of the number of cells that co-stain for 5-HT and ChgA (5-HT–positive/ChgA-positive cells) identified per villi/crypt in the ileum or per crypt in the colon of treated mice (n = 10/group). All data are presented as means ± SD. ∗∗∗∗P < .0001. EC, enterochromaffin cell.

B dentium Stimulates 5-HT Production by Enterochromaffin Cells

Although 5-HT is known to be produced by enterochromaffin cells, it also can be released from mast cells and neurons.77, 78, 79, 80 To determine if B dentium–secreted products, including acetate, were capable of stimulating 5-HT release specifically from enterochromaffin cells, ileal enteroid cultures were generated from adult Swiss Webster mice. These cultures of primary epithelial cells enable examination of epithelial responses independent from other cell and tissues types. B dentium was cultured in a fully defined media termed LDM4 and filtered through a 3-kilodalton filter to collect low-molecular-weight compounds, such as acetate. This filtered, spent media was termed B dentium CM. Enteroids were microinjected with either sterile control LDM4 media, B dentium CM, heat-killed B dentium, B ovatus CM, 5 mmol/L acetate, or 100 ng/mL LPS and incubated overnight. 5-HT concentrations present in the enteroid media were assessed by LC-MS/MS, and 5-HT–positive enterochromaffin cells were visualized by immunostaining. Immunostaining confirmed the presence of 5-HT–positive enterochromaffin cells in both control LDM4 media-injected enteroids and those microinjected with 50% B dentium CM (Figure 5A).
Figure 5

stimulates 5-HT release from enterochromaffin cells in mouse enteroids. (A) Representative images of immunostaining in ileal enteroids, indicating the presence of 5-HT–positive enterochromaffin cells. Inset is image enlarged from original showing enterochromaffin cell morphology and staining pattern. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 50 μm. (B) Bars represent serotonin concentrations released into media from ileal enteroids microinjected with media, 50% uninoculated LDM4, increasing concentrations of B dentium LDM4 CM (5%–50%), 50% B ovatusCM, 5 mmol/L acetate, 106 heat-killed B dentium, or 100 ng/mL LPS (n = 3 wells/group, 4 independent experiments). (C) Enteroid viability as measured via trypan blue staining (4 wells/treatment, 4 independent experiments). Data are expressed as the percentage of viable cells relative to total. (D) SCFA LC-MS/MS analysis of B dentium and B ovatusCM. All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. BD, B dentium conditioned media; HK Bd, heat-killed B dentium; Bo,B ovatus conditioned media.

stimulates 5-HT release from enterochromaffin cells in mouse enteroids. (A) Representative images of immunostaining in ileal enteroids, indicating the presence of 5-HT–positive enterochromaffin cells. Inset is image enlarged from original showing enterochromaffin cell morphology and staining pattern. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 50 μm. (B) Bars represent serotonin concentrations released into media from ileal enteroids microinjected with media, 50% uninoculated LDM4, increasing concentrations of B dentium LDM4 CM (5%–50%), 50% B ovatusCM, 5 mmol/L acetate, 106 heat-killed B dentium, or 100 ng/mL LPS (n = 3 wells/group, 4 independent experiments). (C) Enteroid viability as measured via trypan blue staining (4 wells/treatment, 4 independent experiments). Data are expressed as the percentage of viable cells relative to total. (D) SCFA LC-MS/MS analysis of B dentium and B ovatusCM. All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. BD, B dentium conditioned media; HK Bd, heat-killed B dentium; Bo,B ovatus conditioned media. Importantly, injection of uninoculated bacterial media (LDM4) also was found to have no effect on the release of 5-HT. In contrast, addition of increasing concentrations of B dentium CM (5%–50%) resulted in a dose-dependent increase in the release of 5-HT from mouse ileal enteroids as determined by LC-MS/MS (Figure 5B). Injection of 10% B dentium CM was sufficient to observe an increase in release of 5-HT, although 50% B dentium CM resulted in the greatest stimulation of 5-HT release from mouse ileal enteroids. Likewise, addition of acetate stimulated 5-HT release, albeit not to the same extent as the conditioned media. To determine the specificity of the 5-HT release, enteroids were microinjected with LPS, 106 heat-killed B dentium, or 50% B ovatus CM. Unlike B dentium CM or microinjected acetate, LPS, 106 heat-killed B dentium, or 50% B ovatus CM had no effect on 5-HT release (Figure 5B), indicating that 5-HT release was not a general host response to the presence of bacteria. Addition of B dentium CM did not hinder enteroid viability (Figure 5C). Interestingly, we found that greater percentages of B dentium CM enhanced viability as determined by trypan blue staining. We postulate this effect may be attributed to known anti-apoptotic effects of Bifidobacterium species on the intestinal epithelium., Finally, to confirm the SCFA levels in our media, we examined B dentium– and B ovatus–conditioned media by LC-MS/MS. Similar to our stool levels, we observed that B dentium secreted high levels of acetate in vitro, whereas B ovatus secreted low levels of acetate and propionate (Figure 5D). To confirm these findings in a human model, we used HIEs. Similar to mouse enteroids, HIEs harbor a population of enterochromaffin cells, as seen by 5-HT immunostaining (Figure 6A). Three-dimensional HIEs were microinjected with 50% uninoculated LDM4, 50% B dentium CM, 106 heat-killed B dentium, or 5 mmol/L acetate. As observed in our mouse enteroids, HIEs treated with B dentium CM and, to a lesser degree, acetate had increased levels of 5-HT by LC-MS/MS compared with HIEs treated with media, LDM4, and heat-killed bacteria controls (Figure 6B). Increased viability in 3D HIEs was observed only with the addition of B dentium CM, as assessed by trypan blue staining. We also used 2D HIE monolayers with the same treatment regimen. As expected, we observed increased levels of released 5-HT after incubation with B dentium CM or acetate (Figure 6C). In 2D format, we did not observe changes in cell viability with any treatments.
Figure 6

(A) Representative images of immunostaining in jejunal HIEs, indicating the presence of 5-HT–positive enterochromaffin cells. White outlines highlight enterochromaffin cells. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 100 μm. (B) Bars represent serotonin concentrations in enteroid media after microinjection of 3D HIEs with media, 50% uninoculated LDM4, 50% B dentium CM, 106 heat-killed B dentium, or 5 mmol/L acetate (left) and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). (C) Bars represent serotonin concentrations in 2D enteroid monolayer media after incubation with the same treatment groups and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). (D) Representative images of immunostaining in jejunal tetNGN3 HIEs, induced with 1 μg/mL doxycycline to drive enteroendocrine cell fate. 5-HT–positive enterochromaffin cells are found all over the enteroids, with some enterochromaffin cells outlined in white to highlight cell shape. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 50 μm. (E) Bars represent serotonin concentrations in media after microinjection of 3D tetNGN3 HIEs with media, 50% uninoculated LDM4, 50% B dentium CM, 106 heat-killed B dentium, or 5 mmol/L acetate (left) and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). (F) Bars represent serotonin concentrations in 2D tetNGN3 HIE monolayer media after incubation with the same treatment groups and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. BD CM, B dentium conditioned media; HK Bd, heat-killed B dentium.

(A) Representative images of immunostaining in jejunal HIEs, indicating the presence of 5-HT–positive enterochromaffin cells. White outlines highlight enterochromaffin cells. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 100 μm. (B) Bars represent serotonin concentrations in enteroid media after microinjection of 3D HIEs with media, 50% uninoculated LDM4, 50% B dentium CM, 106 heat-killed B dentium, or 5 mmol/L acetate (left) and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). (C) Bars represent serotonin concentrations in 2D enteroid monolayer media after incubation with the same treatment groups and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). (D) Representative images of immunostaining in jejunal tetNGN3 HIEs, induced with 1 μg/mL doxycycline to drive enteroendocrine cell fate. 5-HT–positive enterochromaffin cells are found all over the enteroids, with some enterochromaffin cells outlined in white to highlight cell shape. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 50 μm. (E) Bars represent serotonin concentrations in media after microinjection of 3D tetNGN3 HIEs with media, 50% uninoculated LDM4, 50% B dentium CM, 106 heat-killed B dentium, or 5 mmol/L acetate (left) and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). (F) Bars represent serotonin concentrations in 2D tetNGN3 HIE monolayer media after incubation with the same treatment groups and enteroid viability as measured via trypan blue staining (right) (n = 3 wells/group; 3 independent experiments). All data are presented as means ± SD. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. BD CM, B dentium conditioned media; HK Bd, heat-killed B dentium. Because enterochromaffin cells represent a small population, we sought to fine-tune the number of enterochromaffin cells, and thus the sensitivity of our assay, by using tetNGN3-HIEs. These HIEs can be induced to overexpress NGN3, a transcription factor that promotes epithelial differentiation into enteroendocrine lineages.,83, 84, 85, 86 In this inducible model system of the human intestinal epithelium, >50% of the cells become enterochromaffin cells as confirmed by 5-HT immunostaining (Figure 6D). Microinjection of 50% B dentium CM into 3D tetNGN3-HIEs resulted in significantly increased release of 5-HT (Figure 6E). Similar to our results from enteroids derived from mouse ileum, microinjection of acetate resulted in stimulation of 5-HT release. The release of 5-HT in tetNGN3 HIEs was approximately 4-fold greater than what was observed in wild-type mouse enteroids. We also observed enhanced viability with administration of B dentium CM. Consistent with 3D enteroids, 2D monolayers of tetNGN3 HIEs released increased 5-HT when exposed to B dentium CM (Figure 6F). We also observed 5-HT release in response to acetate, although these levels were far below that of B dentium CM. To ascertain the role of acetate in B dentium–stimulated release of 5-HT, we removed acetate in the CM by converting it back to acetyl-Co-A. Loss of acetate in our modified B dentium CM reduced the ability of CM to stimulate increased 5-HT release as observed with B dentium CM. However, levels of 5-HT still were greater than in media and LDM4 controls, indicating that other B dentium metabolites contribute to 5-HT release. No changes were observed in viability in this 2D format as well. These data show that B dentium–secreted products, including acetate, can modulate 5-HT production by host enterochromaffin cells.

The 5-HT Reuptake Transporter SERT and Specific 5-HT Receptors Are Up-Regulated by B dentium

Once released, 5-HT can interact with multiple isoforms of the 5-HT receptor present on various cell types within the intestine. Increased local concentrations of 5-HT may impact the expression of these receptors. Therefore, we examined whether 5-HT–receptor expression was affected in our live B dentium in vivo model via qPCR. We found that expression of the colonic 5-HT receptors 2a and 4 (Htr2a and Htr4) were increased significantly in B dentium mono-associated mice (Figure 7A). This approximately 10-fold up-regulation of Htr2a and Htr4 receptors indicates the expected coordinated physiological response to 5-HT release.
Figure 7

(A) Relative fold change in expression of the major 5-HT receptors within the germ-free and B dentium mono-associated mouse colon by qPCR (n = 8/group). (B) Representative images of SERT immunostaining in ileum and colon of germ-free and live B dentium mono-associated mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 100 μm. (C) Relative fold change in expression of Sert within the germ-free and B dentium mono-associated mouse ileum and colon (n = 7–10/group). (D) Relative fold change in expression of Sert in mouse enteroids microinjected with LDM4 control media, 50% B dentium CM, or 5 mmol/L acetate (n = 3/treatment group, 3 independent experiments). (E) Representative images of SERT immunostaining in mouse enteroids microinjected with media, 50% LDM4, 10%–50% B dentium CM, or 5 mmol/L acetate. Scale bar: 100 μm. Inset shows enlarged image of increased staining in enteroids injected with B dentium CM. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. All data are presented as means ± SD. ∗∗P < .01, ∗∗∗P < .001, ∗∗∗∗P < .0001.

(A) Relative fold change in expression of the major 5-HT receptors within the germ-free and B dentium mono-associated mouse colon by qPCR (n = 8/group). (B) Representative images of SERT immunostaining in ileum and colon of germ-free and live B dentium mono-associated mice. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. Scale bar: 100 μm. (C) Relative fold change in expression of Sert within the germ-free and B dentium mono-associated mouse ileum and colon (n = 7–10/group). (D) Relative fold change in expression of Sert in mouse enteroids microinjected with LDM4 control media, 50% B dentium CM, or 5 mmol/L acetate (n = 3/treatment group, 3 independent experiments). (E) Representative images of SERT immunostaining in mouse enteroids microinjected with media, 50% LDM4, 10%–50% B dentium CM, or 5 mmol/L acetate. Scale bar: 100 μm. Inset shows enlarged image of increased staining in enteroids injected with B dentium CM. Host nuclei were counterstained with 4′,6-diamidino-2-phenylindole. All data are presented as means ± SD. ∗∗P < .01, ∗∗∗P < .001, ∗∗∗∗P < .0001. In addition to interacting with receptors, 5-HT can be transported into neighboring enterocytes or neurons via the 5-HT reuptake transporter (SERT). We examined the impact of B dentium–secreted products on SERT levels by immunostaining and qPCR in vivo and in our enteroid models. Immunofluorescence staining was used to examine the SERT protein in tissue sections, showing an increased fluorescence signal in both the ileum and colon of B dentium mono-associated mice relative to controls (Figure 7B). B dentium mono-associated mice yielded significantly increased expression of Sert mRNA in both the ileum and colon relative to germ-free mice (Figure 7C). Increased epithelial SERT was mirrored in enteroids microinjected with B dentium CM. B dentium CM (10%–50%), but not acetate, stimulated dose-dependent increases in Sert mRNA expression (Figure 7D) and SERT protein (Figure 7E). These data suggest that B dentium secretes other product(s) besides acetate, capable of up-regulating SERT.

B dentium Increases Hippocampal 5-HT–Receptor Expression and Partially Restores 5-HT–Dependent Behavior

To determine if B dentium colonization could alter the central nervous system (CNS) serotonergic system we examined serotonin-receptor expression in the brains of germ-free and B dentium mono-associated mice. Based on the significant up-regulation observed in the gut, and its known role in behavioral processes, we focused on expression of the excitatory serotonin receptor Htr2a using RNA ISH. Expression of Htr2a was assessed in the hippocampus and characterized by hippocampal region (dentate gyrus, CA1, CA2, and CA3) and by strength of expression (Figure 8A). Cells were categorized as weak, media, or strongly expressing based on fluorescence intensity as previously established (Figure 8B). B dentium mono-associated mice were observed to have significantly increased expression of Htr2a in the CA1 region of the hippocampus relative to germ-free animals, although no significant differences were detected in the other hippocampal regions examined (Figure 8C). More specifically, a significant increase in the percentage of cells in the strong or media levels of Htr2a in the CA1 region was observed.
Figure 8

increases hippocampal expression ofand normalizes behavior. (A) Representative images of the Htr2a in situ hybridization staining within the hippocampal formation of germ-free and B dentium mono-associated mice. (B) Representative images of cells categorized as expressing Htr2a with cells labeled as strong (red), media (yellow), weak (blue), or no expression (black). (C) Bars represent cells categorized as strong, media, weakly, or not expressing Htr2a in each region of the hippocampal formation (CA1, CA2, CA3, dentate gyrus [DG]) (n = 4 sections/mouse with n = 5–6/group). (D) Representative images of marble bury test before (upper panel) and after (lower panel) the test. (E) Bars represent the percentage of total marbles buried during the test by mice in each treatment group (n = 10–13/group). (F) Bars represent time taken by mice to cross a beam in the balance beam test (n = 10/group). (G) Footprint analysis showing the sway, stance, and stride measurements (distance in cm) averaged for each mouse (n = 10–12/group). BD, B dentium; GF, germ-free.

increases hippocampal expression ofand normalizes behavior. (A) Representative images of the Htr2a in situ hybridization staining within the hippocampal formation of germ-free and B dentium mono-associated mice. (B) Representative images of cells categorized as expressing Htr2a with cells labeled as strong (red), media (yellow), weak (blue), or no expression (black). (C) Bars represent cells categorized as strong, media, weakly, or not expressing Htr2a in each region of the hippocampal formation (CA1, CA2, CA3, dentate gyrus [DG]) (n = 4 sections/mouse with n = 5–6/group). (D) Representative images of marble bury test before (upper panel) and after (lower panel) the test. (E) Bars represent the percentage of total marbles buried during the test by mice in each treatment group (n = 10–13/group). (F) Bars represent time taken by mice to cross a beam in the balance beam test (n = 10/group). (G) Footprint analysis showing the sway, stance, and stride measurements (distance in cm) averaged for each mouse (n = 10–12/group). BD, B dentium; GF, germ-free. We next sought to define if B dentium–mediated changes in the CNS serotonergic system also would result in behavioral changes. Previous studies with germ-free mice have established that these mice show an abnormal, “anxiolytic“ or reduced-anxiety phenotype, as well as an increased propensity to engage in repetitive behaviors such as grooming.,,87, 88, 89, 90 The marble burying test is a simple test that is used commonly to quantify repetitive and/or anxiety-like behavior in rodents, but also is associated with typical mouse digging behavior.91, 92, 93, 94, 95, 96 This test has been used previously to test 5-HT active compounds such as selective serotonin re-uptake inhibitors. Furthermore, the 5-HT2A–receptor antagonist YM992 has been shown to reduce marble burying, further implicating the association between microbial-induced modulation of this receptor and the behavioral changes observed.91, 92, 93, 94, 95, 96 Swiss Webster mice with a complete gut microbiota (SPF) buried on average 25% (25.5% ± 4.5%) of the marbles encountered during the test (Figure 8D and E). In contrast, germ-free mice buried significantly fewer marbles (6.8% ± 1.1%) relative to the SPF cohort. B dentium monocolonized mice buried a significantly higher percentage (15.8% ± 3.5%) of marbles than germ-free mice, but not as many as the SPF cohort. These data suggest that the reduced-anxiety phenotype observed in germ-free mice was partially normalized by the monocolonization with B dentium, even though this colonization was short term and was performed later in life. To confirm that our observed marble burying phenotype was not caused by differences in locomotor coordination between germ-free compared with B dentium mono-associated mice, we also assessed locomotion using the balance beam test (Figure 8F) and footprint analysis (Figure 8G). No differences were observed between germ-free and live B dentium mono-associated mice, suggesting that monocolonization does not affect motor coordination. These findings add to our previous work, which found no difference in overall motor activity between Bifidobacterium-colonized mice and germ-free in the open field test. Overall, these data show that B dentium modulates the serotonergic system in both the intestine and the brain. This modulation likely influences behavior, and suggests that supplementation with a single, carefully selected, bacterial strain may be able to partially rescue behavioral deficits induced by shifts in the intestinal microbiota. These data further highlight the importance of Bifidobacterium species, and specifically B dentium, in the adult microbiome–gut–brain axis.

Discussion

Recent studies have highlighted a role for the gut microbiota in regulation of 5-HT; however, the mechanism(s) for this regulation was previously unclear. Herein, we show that mono-association of animals with the commensal B dentium significantly modulates the host serotonergic system. Our findings indicate that B dentium colonizes the intestinal mucus layer where it delivers secreted metabolites, such as acetate, to the underlying epithelium. Consistent with other reports, we have confirmed that acetate is capable of stimulating enterochromaffin cells to secrete 5-HT.,,, We have extended these previous findings that rely largely on cancer-based cell lines and ex vivo methods by using mouse and human intestinal enteroid cultures, which more closely recapitulate the intestinal epithelium. We also show that B dentium–secreted products apart from acetate are capable of stimulating 5-HT release. We included heat-killed B dentium and commensal B ovatus in our study to show that select viable gut microbes modulate 5-HT. This work shows that generation of microbial compounds, including acetate, by a single bacterial species modulates 5-HT production in a gnotobiotic mouse model. In addition to the increased production and release of 5-HT, mice mono-associated with B dentium showed increased expression of select 5-HT receptors in both the gut and the brain, which may modulate several downstream signaling targets. As a result, B dentium may represent a next-generation category of probiotics capable of modulating 5-HT and the microbiome–gut–brain axis. Enteroid cell cultures confirmed that both B dentium and acetate elicit 5-HT release from enterochromaffin cells within the intestinal epithelium. This is consistent with findings from other groups that have noted that a complex gut microbiota regulates peripheral 5-HT concentrations.17, 18, 19, 20 Enterochromaffin cells act as chemical and mechanical transducers, serving to connect the intestinal environment and the enteric nervous system. Enterochromaffin cells respond to a number of stimuli in the luminal environment such as SCFAs, pH, oxygen, amino acids, monosaccharides, catecholamines (dopamine, epinephrine, norepinephrine, γ-aminobutyric acid [GABA]), purines (adenosine and adenosine triphosphate), and mechanical stimuli.,,97, 98, 99, 100, 101, 102 Multiple groups have shown a role for SCFAs in the stimulation of 5-HT release.,,,,, Mouse enteroids (referred to in the literature by some as intestinal organoids) derived from small and large intestine have been shown to secrete 5-HT in response to acetate and propionate. By using ex vivo mouse ileum, Nzakizwanayo et al found that secreted products from the acetate-producing E coli Nissle 1917 increased extracellular 5-HT concentrations. However, addition of another human gut commensal, E coli MG1655, which produces similar levels of acetate, was unable to stimulate 5-HT secretion. These findings implicate additional bacterial metabolites that perhaps work in coordination with acetate to stimulate 5-HT release. These findings are consistent with our work, which suggests that other B dentium metabolites also influence 5-HT release. Enterochromaffin cells also are responsive to GABA. We previously showed that B dentium is capable of producing GABA, and B dentium–produced GABA may contribute to 5-HT release in our model as well. Lactate is also known to activate GPR132 on enterochromaffin cells, and the B dentium genome has annotated enzymes necessary for the fermentation of glucose and fructose to lactic acid. As a result, lactate also could promote 5-HT from enterochromaffin cells. Enterochromaffin cells are known to express functional Toll-like receptors, and addition of heat-killed Lactobacillus brevis SBC880, another lactic acid–producing bacteria, was shown to stimulate 5-HT release from EC-like RIN-14B cells and mouse small intestinal loops. Our in vivo and in vitro work with heat-killed B dentium indicates that B dentium membrane components do not contribute to enterochromaffin cell release of 5-HT. At present, it is unclear what components of B dentium metabolites contribute to 5-HT stimulation, but this is an exciting area meriting future investigation In addition to stimulation of 5-HT release, B dentium may be altering the conjugation of 5-HT, thereby contributing to the bioactive 5-HT pool. A substantial proportion of 5-HT found in germ-free mice exists as glucuronide-conjugated 5-HT. In contrast, only 6% of 5-HT is glucuronide-conjugated in conventionalized mice (germ-free mice colonized with SPF feces). As a result, the majority (90%) of 5-HT exists in the bioactive state in conventionalized free mice, while germ-free mice have a deficit of bioactive 5-HT. Bacterial enzymes such as β-glucuronidase have been proposed to deconjugate 5-HT-O-glucuronide. B dentium is known to show β-glucuronidase activity and thus may be contributing to increased bioactivity of 5-HT. Similar to other published findings examining microbial-induced 5-HT release,,,,109, 110, 111, 112, 113, 114, 115 we observed significant amounts of 5-HT secreted into the intestinal lumen in mice colonized with B dentium compared with germ-free controls. Once in the lumen, 5-HT can interact with other members of the gut microbiota. 5-HT has been documented to stimulate the growth of E coli, Enterococcus faecalis, and Rhodospirillum rubrum in culture., 5-HT also has been shown to serve as a quorum-sensing molecule in Pseudomonas aeruginosa. To the best of our knowledge, no role has been identified previously for 5-HT in modulation of growth of Bifidobacterium species. However, during development, Bifidobacterium species act in various ways to prime the intestinal environment for subsequent colonizers, and they participate in several known interspecies cross-feeding relationships., Modulation of 5-HT stores by B dentium therefore also may function in this capacity in adult animals, thereby influencing gut microbial composition. 5-HT is known to mediate several functions, including intestinal motility. TPH-2–deficient mice, which lack neuronal-generated 5-HT, show increased transit time and colonic motility. In addition, Spencer et al found that colon peristalsis still could occur after removing the mucosa (and thus the enterochromaffin cells) from mouse and guinea pig colon, highlighting the importance of enteric nervous system (ENS) 5-HT for motility. Enterochromaffin 5-HT also has been shown to participate in colonic motility. TPH-1–deficient mice, which lack enterochromaffin-generated 5-HT, show slower in vitro propulsion of large fecal pellets and an absence of reflex activity in response to mucosal stimulation. In our mice, we did not observe any changes in Tph-2 mRNA or find noticeable differences in stool consistency (data not shown). However, no definitive colonic motility tests were performed, so at present it remains unclear whether colonic motility is altered in our mice. These are important considerations for future work. Modulation of the gut–brain axis by the microbiome has long been linked to alterations in host behavior. Addition of other Bifidobacterium species affect various host behaviors, including repetitive and anxiety-like behaviors. For instance, supplementation of SPF mice and rats with commensal Bifidobacterium longum had anxiolytic effects,, whereas Bifidobacterium infantis alleviated depressive-like behaviors in a rat model of maternal separation. Recently, B longum NCC3001 was found to improve depression scores and induce pronounced changes in brain activity in human patients with irritable bowel syndrome. Our work also has shown that neonatal colonization with a consortium of human-derived Bifidobacterium species, including B dentium, affects adult rodent behavior including anxiety and hyperactivity. These studies show that infant-type Bifidobacteria modulate select host behaviors via modifications to neurodevelopmental processes., We hypothesized that B dentium–produced acetate stimulates local 5-HT production and release by enterochromaffin cells. We speculate that B dentium–mediated modulation of other components of the serotonergic system, such as 5-HT–receptor expression in both the gut and the brain, result in the behavioral changes observed. Because dysregulation of the serotonergic system is implicated in disease pathogenesis in both the gut and the brain, modulation of this system by a particular microbe may provide new strategies to target these disorders. 5-HT bioavailability and receptor expression has long been linked to behavior and has been shown to have effects on both repetitive behaviors as well as anxiety-like behaviors.128, 129, 130, 131, 132, 133 Numerous studies using germ-free animals have shown that the gut microbiota influences anxiety-like behavior and that germ-free mice show decreased anxiety,,87, 88, 89 and an increased stress response., Colonization with microbes early in life has been shown to normalize these aberrant behaviors. We therefore predicted that B dentium mono-association may affect these behaviors via modulation of the host CNS serotonergic system. Our results show that germ-free mice show decreased species-typical anxiety behaviors and that colonization with a single bacterial species, in this case B dentium, partially normalizes anxiety-like behavior. We speculate that this may be owing to bacterial-induced changes to the serotonergic system. Several studies have documented the ability of the microbiota as a whole to regulate the serotonergic system,,,,,,,,, however, this study shows that the Htr2a is expressed differently in the brain based on the microbial-colonization status of the gut. Htr2a mediates excitatory neurotransmission and Htr2a knockout mice show decreased anxiety. Studies in Parkinson’s disease patients also have identified an association between HTR2A expression and impulse control and repetitive behavior. Although we speculate that Htr2a expression may be involved in our mouse behavior, our findings do not rule out the possibly that other signaling pathways are involved and HTR2A may not be the sole mediator of all our results. To assess the role of intestinal and neuronal HTR2A in mediating our behavior phenotype, region-specific Htr2a knockout mice could be used. These studies would definitively identify a role for HTR2A in B dentium–modulated behavior effects. Several possible mechanisms may facilitate cross-talk between microbes and the CNS. Microbes have been shown to elicit signals to the CNS via the vagal nerve., Supplementation of B longum was shown to have an anxiolytic effect in a model of chronic colitis and this effect was abrogated when mice were vagotomized before colitis. The microbiota also has been shown to activate the mucosal immune system, which may alter epithelial permeability, activate nociceptive sensory pathways, and dysregulate the ENS. This may be through the production or stimulation of neurotransmitters such as 5-HT, GABA, histamine, melatonin, and acetylcholine, which can modulate afferent sensory nerves., Our work indicates that certain metabolites produced by Bifidobacterium, such as acetate (a SCFA), can stimulate release of 5-HT, which may act peripherally or may stimulate the ENS directly. This connection supports recent literature, which documents release of 5-HT from enterochromaffin cell cultures treated with SCFAs.,,,,, Recent studies also have shown that bacterial peptidoglycan derived from the commensal gut microbiota can be translocated into the brain and sensed by specific pattern-recognition receptors of the innate immune system, which may serve as a method of gut–brain communication. It is additionally possible that small-molecule bacterial proteins or metabolites may cross the blood-brain barrier and directly modify the host CNS. Probiotic strains, particularly Lactobacillus and Bifidobacterium species, have been hypothesized to beneficially influence mammalian health and disease, via different signaling pathways including the serotonergic system.147, 148, 149, 150, 151, 152 Our findings support the modulation of the serotonergic system by a model gut microbe, B dentium, and provide a potential mechanism by which select microbes and their metabolites can promote endogenous, localized 5-HT biosynthesis. We speculate this may be an important bridging signal in the microbiome–gut–brain axis.

Materials and Methods

Bacterial Strains and Microbiological Culture Conditions

B dentium ATCC 27678 was cultured anaerobically in de Man, Rogosa and Sharpe (MRS) media (Difco, Franklin Lakes, NJ) or in a fully defined media, Lactic Acid Bacteria Defined Media 4 (LDM4). B ovatus ATCC 8483 was cultured anaerobically in brain–heart–infusion broth (BHI) (Difco) supplemented with 2% yeast extract and 0.2% cysteine or in a Chemically Defined Minimal Media (CDMM). All cultures were grown in an Anaerobe Systems (Morgan Hill, CA) AS-580 anaerobic chamber supplied with a mixture of 10% CO2, 5% H2, and 85% N2. To heat-kill bacteria, B dentium was grown in MRS overnight, centrifuged at 5000 × g for 10 minutes to pellet bacteria, and the pellet was washed 2 times with sterile phosphate-buffered saline (PBS). PBS suspensions were heated at 60°C for 30 minutes. Cell nonviability was confirmed by plating on MRS agar overnight anaerobically at 37°C.

B dentium Conditioned Media and Negative Media Controls

For in vitro enteroid experiments, B dentium cultures were grown overnight in MRS. At the exponential phase these cultures were used to inoculate LDM4 (OD600nm adjusted to 0.1) and incubated anaerobically at 37°C for 24 hours. In LDM4, B dentium reached OD600nm of 1.87 ± 0.3, corresponding to approximately 4 × 108 colony-forming units (CFUs). The bacteria were centrifuged to remove cells (5000 × g, 10 min) and the supernatant was adjusted to pH 7.0 by addition of NaOH. The pH-adjusted supernatant was filtered through a 0.2-μm membrane filter (Millipore, San Diego, CA). Cultures were filtered with a 3-kilodalton filter according to the manufacturer’s instructions (Amicon Ultracel, 3 kilodaltons; Millipore) and lyophilized. Lyophilized supernatant was resuspended in mouse or human enteroid differentiation media to generate B dentium–conditioned media (CM). Uninoculated LDM4 bacterial media was treated using the same conditions to generate negative LDM4 media control. Enteroid culture media alone was used as negative media controls. To remove acetate from B dentium CM, we incubated acetyl-coenzyme A synthetase (A1765; Sigma, St. Louis, MO), 2 mmol/L coenzyme A (C3144-10MG; Sigma), 20 mmol/L adenosine triphosphate (A7699; Sigma), and 50 mmol/L MgCl2 (M8266; Sigma) and incubated aerobically at 37°C for 3 hours. Loss of acetate was confirmed using an Acetate Colorimetric Assay Kit (cat. MAK086; Sigma) according to the manufacturer’s details.

Gnotobiotic Mouse Models and Intestinal Bacterial Colonization

Animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine (Houston, TX) in accordance with all guidelines set forth by the US National Institutes of Health (Baylor College of Medicine Institutional Animal Care and Use Committee approved protocol AN-6706). Germ-free Swiss Webster Mice were purchased from Taconic (Renssalaer, NY) and bred in the Gnotobiotic Animal Facility at Baylor College of Medicine to create an outbred colony of germ-free mice. Adult (age, 6–9 mo) male and female mice from this colony were maintained under germ-free or gnotobiotic conditions in separate flexible isolators fed with high-efficiency particulate–filtered air. Mice were kept under filter-top cages (3–5 mice per cage) with ad libitum access to irradiated food and water. Mice were provided with sterile Select Rodent 50 IF/6F auto 5V0F chow (cat. 3002875-703; Lab Diet.com, St. Louis, MO). To mono-associate germ-free mice, B dentium ATCC 27678 and B ovatus ATCC 8483 were grown in the culture conditions described earlier. Bacteria were harvested in log-phase growth and the OD600 of the culture was used to approximate cell viability based on previous growth curve data. Cell viability in the gavage mixture was verified by dilution plating on MRS or BHI agar immediately before the gavage procedure and was confirmed to be approximately 1.6 × 109 viable cells per milliliter. The cultures were prepared anaerobically and remained in anaerobic tubes until administered to the mice. Mice were oral-gavaged with 3.2 × 108 CFU/mL (in 0.2 mL) of live B dentium and 3.0 × 108 CFU/mL-1 (in 0.2 mL) of live B ovatus. For heat-killed treatment, mice received 3.2 × 108 CFU/mL-1 (in 0.2 mL) of heat-killed B dentium via oral gavage (as calculated from OD600). Control mice received only sterile MRS broth. Mouse numbers were as follows: germ-free (MRS broth): males = 27, females = 30; live B dentium experiments: males n = 28, females n = 29; live B ovatus: males = 5, females = 5; and heat-killed B dentium males = 5, and females n = 5. Oral gavages were administered once every other day for 1 week with 1 supplemental gavage a week later (4 total treatments). Mono-association and germ-free status were monitored over the course of the experiment by plating individual fecal samples on MRS, BHI, and blood agar (Hardy Diagnostics, Santa Maria, CA). Plates were incubated at 37°C aerobically and anaerobically and examined for growth at 24 and 48 hours. The weight of each mouse was monitored upon exiting the isolators (on day 17), and mice were euthanized 72 hours after the last gavage. For behavior analysis, 20 SPF mice (males = 10, females = 10) mice were used in this study.

Mouse Intestinal Preparation

For tissue preparation, the small and large intestine carefully were removed immediately after euthanasia and dissected rapidly. Mouse terminal ileum (3–6 cm above the cecum) and mouse distal colon were cut into 2 sections. One segment was collected in TRIzol (Thermo Fisher, Waltham, MA) for RNA extraction and gene expression analysis. The other segment was fixed in Carnoy’s fixative, embedded with paraffin, and sectioned.

Fecal Matter Processing for Mass Spectral Analysis

Samples of fecal content (50–100 mg) were homogenized manually and suspended in 200 μL of 99% methanol on ice. The mixture was centrifuged at 21,130 × g for 2 minutes at 4°C. The supernatant (fecal water) was transferred into tubes containing 3-kilodalton filters and centrifuged at 14,000 × g for 30 minutes at room temperature. The filtrate (size, ≤3 kilodaltons) then was removed and stored at -80°C. Liquid chromatography with tandem mass spectrometry (LC-MS/MS) was used to quantify 5-HT concentrations from this preparation. For analysis of intestinal luminal content, 4 cm of terminal ileum and 4 cm of midcolon were flushed by blunted syringe with 500 μL sterile PBS. The samples then were processed as described earlier for the fecal water preparation and stored at -80°C.

Quantification of Serotonin Concentration by LC-MS/MS

Chemicals and reagents

Serotonin hydrochloride, formic acid (FA), and heptafluorobutyric acid were obtained from Sigma Aldrich (St. Louis, MO). Serotonin-d4 hydrochloride was obtained from Santa Cruz Biotech (Dallas, TX). Optima LC/MS-grade water and acetonitrile (ACN) were obtained from Thermo-Fisher Scientific (Waltham, MA). Individual calibration standards were prepared at serotonin concentrations of 0.98, 3.9, 15.6, 62.5, 250, and 1000 ng/mL using an aqueous internal standard solution that contains 450 ng/mL of serotonin-d4 as the diluent.

Sample preparation

To prepare samples for LC-MS analysis, frozen samples were thawed and immediately vortexed for 1 minute. The samples then were centrifuged at 10,000 × g for 5 minutes. Ninety microliters of an aqueous internal standard solution containing 500 ng/mL of serotonin-d4 was added to a 10-μL volume of each sample and vortex-mixed for 15 seconds; the internal standard (IS) concentration was consistent between calibration standards and samples. Samples then were loaded into 0.5-mL autosampler vials and submitted for LC-MS/MS analysis.

Chromatography

Chromatography was performed on a Shimadzu (Kyoto, Japan) Nexera-XR high-performance liquid chromatography system consisting of an SIL-20ACxr autosampler, a CTO-20AC column oven, and 2 LC-20ADxr binary pumps. Sample (5 μL) was loaded onto a Phenomenex Luna C18(2) (150 × 1 mm, 3 μm, 100 Å pore) (Torrance, CA) reverse-phase column equipped with a Phenomenex Security Guard C18 (4 × 2 mm) guard column. The aqueous mobile phase A (phase A) consisted of H2O:ACN:FA:heptafluorobutyric acid (99.3:0.5:0.1:0.1 v/v/v/v) and the organic mobile phase B (phase B) consisted of methanol:FA (99.9:0.1 v/v). The mobile phase flow rate was 100 μL/min. The elution gradient was optimized as follows: started from 5% phase B and increased to 60% phase B over 9 minutes; decreased from 60% phase B back to 5% phase B over 0.1 minutes; and was maintained at 5% phase B for the duration of the 12-minute chromatographic run.

Mass spectrometry

Selected reaction monitoring was performed on a Sciex (Framingham, MA) 6500 QTRAP MS system with a Turbo V source and TurboIonSpray probe installed. The MS was operated in the positive ion mode under the following conditions: curtain gas: 20 psi; collision gas: high; spray voltage: + 5 kV; ion source gas 1: 25 psi; ion source gas 2: 25 psi; interface heater temperature: 200°C; Q1 and Q3 resolution: unit/unit; dwell time: 220 ms; declustering potential (DP): +20 V; entrance potential (EP): +8 V; and collision exit potential (CXP): +10 V. The instrument was calibrated using Sciex PPG calibration standard and tuned to the manufacturer’s specifications. Selected-reaction monitoring (SRM) transitions monitored for serotonin were 177.1 → 160.1 (collision energy [CE]: +17 electron volts [eV]) and 177.1 → 115.1 (CE: +38 eV). For serotonin-d4, the SRM transitions 181.1 → 164.1 (CE: +17 eV) and 181.1 → 119.1 (CE: +38 eV) were monitored. Data were acquired with Analyst Software (SCIEX, Framingham, MA, version 1.6.2) and quantification was performed using Multiquant Software (SCIEX version 3.0.1).

Quantification of SCFA Concentration by LC-MS/MS

Optima LC/MS-grade ACN, FA, methanol, and water were obtained from Thermo-Fisher Scientific. Authentic SCFA reference materials (acetic acid, propionic acid, butyric acid, isobutyric acid, pentanoic acid, isopentanoic acid, and 2-methylbutyric acid) were obtained from Millipore-Sigma (Burlington, MA). Reagents used in the derivatization of the SCFAs include aniline and [13C6]-aniline (for carbon-13 labeled IS preparations) and were obtained from Millipore-Sigma, and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 2-mercaptoethanol, and succinic acid were obtained from Thermo-Fisher Scientific. Derivatization reactions for the preparation of the analytes (N-phenyl-SCFA derivatives) and corresponding IS (N- [(13C6)-phenyl]-SCFA derivatives) were performed as previously described. Individual calibration standards were prepared at N-phenyl SCFA derivative concentrations of 9.8, 39.0, 156, 625, 2500, and 10,000 nmol/L using an internal standard solution that contains 2250 nmol/L of [13C6]-phenyl-SCFA derivatives as the diluent.

Sample derivatization procedures

Overnight anaerobic cultures of B dentium in LDM4 media and B ovatus in CDMM media were used for SCFA analysis. Before sample derivatization, each filter-sterilized media sample was diluted 2-fold in ACN. The SCFA-derivatization reaction for each media sample was performed by mixing a 10-μL volume of the diluted media sample, a 100-μL volume of a 100-mmol/L aniline solution, and a 50-μL volume of a 100 mmol/L 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride solution. Each sample mixture then was vortex-mixed for 20 seconds, incubated at +4°C for 2 hours, and then quenched by the addition of 50-μL volumes of a 100-mmol/L mercaptoethanol solution and a 250-mmol/L succinic acid solution followed by an additional 2 hour incubation at +4°C. After quenching, a 10-μL volume of the derivatized media sample was diluted in a 90-μL volume of an IS solution that contained 2500 nmol/L of [13C6]-phenyl-SCFA derivatives as the diluent—the IS concentration was consistent between calibration standards and samples. Fecal content from germ-free, B dentium mono-associated, and B ovatus mono-associated mice was stored at -80°C until analysis. The wet weight of fecal material was determined gravimetrically, and an appropriate volume of an ice-cold 1:1 ACN:water solution was added to each sample to obtain a normalized fecal material density of 0.1 mg/μL of solvent. The SCFA-derivatization reaction for each fecal sample was performed by mixing an 85-μL volume of the sample extract, a 10-μL volume of a 100-mmol/L aniline solution, and a 5-μL volume of a 100-mmol/L 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride solution. Each sample mixture then was vortex-mixed for 20 seconds, incubated at +4°C for 2 hours, and then quenched by the addition of a 6.0-μL volume of a 100 mmol/L mercaptoethanol solution, a 9.4-μL volume of a 250-mmol/L succinic acid solution, and 14.6 μL of water followed by an additional 2 hour incubation at +4°C. After quenching, the derivatized fecal samples were diluted 10-fold in a 20:80 acetonitrile:water solution, and then diluted further by the addition of a 10-μL volume of the diluted derivatized fecal sample in a 90-μL volume of an IS solution that contained 2500 nmol/L of ([13C6]-N-phenyl-SCFA) derivatives as the diluent—the IS concentration was consistent between calibration standards and samples.. Chromatography was performed using the same high-performance liquid chromatography system as described for the serotonin measurements earlier. A derivatized sample (5 μL) was loaded onto a Restek Viva BiPh Biphenyl (150 × 1 mm, 5 μm, 300 Å pore) (Bellefonte, PA) reverse-phase column equipped with a Restek Viva BiPh Biphenyl (10 × 2.11 mm, 5 μm) guard column. The aqueous mobile phase (phase A) consisted of water:FA (99.9:0.1 v/v) and the organic mobile phase (phase B) consisted of ACN:FA (99.9:0.1 v/v). The mobile phase flow rate was 200 μL/min. The elution gradient was optimized as follows: held at 5% B for 2 minutes; increased from 5% B to 50% B over 7 minutes; reduced from 50% B to 5% B over 0.1 minutes; and maintained at 5% B for the duration of the 12-minute chromatographic run. SRM scanning was performed using the same MS system described earlier. The MS was operated in the positive ion mode under the following conditions: curtain gas: 20 psi; collision gas: high; spray voltage: + 5 kV; ion source gas 1: 25 psi; ion source gas 2: 25 psi; interface heater temperature: 200°C; Q1 and Q3 resolution: unit/unit; dwell time: 20 ms; and CXP: +10 V. The instrument was calibrated using the Sciex PPG calibration standard and tuned to the manufacturer’s specifications. The molecule-specific LC-MS/MS parameters for all of the N-phenyl-SCFA and ([13C6]-N-phenyl-SCFA) derivatives are listed in Table 1.
Table 1

LC-MS/MS Transitions and Molecule-Specific Parameters for Selected Reaction Monitoring of the N-Phenyl Derivatives of SCFAs and their Carbon-13–Labeled Internal Standard Compounds

Q1, m/zQ3, m/zTime, mSIDCE, eVDP, VEP, VCXP, V
136.19420N-phenyl acetamide 136>94+22+60+9+15
136.17720N-phenyl acetamide 136>77+40+60+9+15
142.11002013C6-N-phenyl acetamide 136>100+22+60+10+15
142.1842013C6-N-phenyl acetamide 136>84+51+60+10+15
150.19420N-phenyl propanamide 150>94+22+70+9+15
150.17720N-phenyl propanamide 150>77+42+70+9+15
156.11002013C6-N-phenyl propanamide 156>100+26+60+10+15
156.182.92013C6-N-phenyl propanamide 156>82.9+45+60+10+15
164.19420N-phenyl butanamide 164>94+23+75+9+15
164.17720N-phenyl butanamide 164>77+45+75+9+15
170.11002013C6-N-phenyl butanamide 170>100+25+60+10+15
170.182.92013C6-N-phenyl butanamide 170>82.9+49+60+10+15
164.19420N-phenyl isobutanamide 164>94+24+72+9+15
164.17720N-phenyl isobutanamide 164>77+46+72+9+15
170.11002013C6-N-phenyl isobutanamide 170>100+24+72+9+15
170.182.92013C6-N-phenyl isobutanamide 170>82.9+46+72+9+15
178.19420N-phenyl pentanamide 178>94+23+80+9+15
178.17720N-phenyl pentanamide 178>77+48+80+9+15
184.11002013C6-N-phenyl pentanamide 184>100+23+80+9+15
184.182.92013C6-N-phenyl pentanamide 184>82.9+48+80+9+15
178.19420N-phenyl isopentanamide 178>94+22+80+9+15
178.17720N-phenyl isopentanamide 178>77+48+80+9+15
184.11002013C6-N-phenyl isopentanamide 184>100+22+80+9+15
184.182.92013C6-N-phenyl isopentanamide 184>82.9+48+80+9+15
178.19420N-phenyl 2-methylbutanamide 178>94+23+80+9+15
178.17720N-phenyl 2-methylbutanamide 178>77+49+80+9+15
184.11002013C6-N-phenyl 2-methylbutanamide 184>100+23+80+9+15
184.182.92013C6-N-phenyl 2-methylbutanamide 184>82.9+49+80+9+15

CD, charged detection; CE, collision energy; CXP, collision-cell exit potential; EP, entrance potential; eV, electron volt; V, volts.

LC-MS/MS Transitions and Molecule-Specific Parameters for Selected Reaction Monitoring of the N-Phenyl Derivatives of SCFAs and their Carbon-13–Labeled Internal Standard Compounds CD, charged detection; CE, collision energy; CXP, collision-cell exit potential; EP, entrance potential; eV, electron volt; V, volts.

Mouse and Human Enteroid Cultures

To create mouse intestinal enteroids, Swiss Webster mice were anesthetized with isoflurane before euthanization by cervical dislocation. Tissues were dissected rapidly and enteroids were generated as previously described. Briefly, a 5-cm length of terminal ileum (<10 cm proximal to the cecum) was excised, washed with ice-cold PBS (Gibco, Gaithersburg, MD), and opened longitudinally. The ileum then was cut into approximately 1-cm length pieces and placed in a 15-mL conical tube containing 5 mL of ice-cold PBS and 3 mmol/L EDTA (Gibco). The tubes were incubated at 4°C rocking for 30 minutes. Crypts were disrupted mechanically by shaking in 5 mL of ice-cold PBS with D-sorbitol and sucrose and collected after filtering through a 70-μm cell strainer (cat. 431751; Corning, Corning, NY). Crypts were centrifuged, resuspended in Matrigel (Corning), and incubated with IntestiCult Organoid Growth media (cat. 06005; StemCell Technologies, Vancouver, Canada) containing 2% penicillin-streptomycin (Life Technologies, Carlsbad, CA). All enteroids were passaged more than 2 times to ensure no tissue fragments remained. Enteroids were differentiated by adding media without Wnt and incubated at 37°C with 5% CO2 for 5 days before use. HIEs were generated from adult jejunum by the Texas Medical Center Digestive Diseases Center Gastrointestinal Experimental Model Systems (GEMS) Core at Baylor College of Medicine, as previously described.46, 47, 48 Established HIE cultures from patient J2 were used. Complete HIE media without growth factors, with growth factors, and differentiation media were prepared as previously described., In addition to the established J2 HIE line, tetracycline-inducible (tet)-Neurogenin-3 (NGN3)-expressing HIEs were created using lentivirus transduction as previously described. All HIEs were grown as 3-dimensional (3D) cultures and as flat 2-dimensional (2D) monolayers on 96-well plates as described in a previously published protocol.49, 50, 51, 52, 53, 54, 55, 56 tetNGN3 HIEs were treated with 1 μg/mL doxycycline for 4 days in differentiation media to induce NGN3 expression and drive enteroendocrine cell fate. Differentiated normal HIEs, tetNGN3 HIEs, and mouse enteroids grown in 3 dimensions were microinjected as previously described using a Nanoject microinjector (Drummon Scientific Company, Broomall, PA) with an injection volume of 16.5 nL. Enteroids were injected with either enteroid media (negative culture media control), uninoculated LDM4 media (in enteroid media), B dentium–CM (in enteroid media), or 5 mmol/L sodium acetate (cat. S5636; Sigma-Aldrich) in enteroid media. As negative controls, enteroids also were microinjected with 1 μg/mL lipopolysaccharide (LPS) (derived from E coli O111:B4, tlrl-3pelps; InvivoGen, San Diego, CA) or heat-killed B dentium. For 2D HIE and tetNGN3 HIE monolayers, treatments were added apically to wells. All enteroids (mouse and human being) were incubated overnight for 16 hours. Supernatant from each well was collected to quantify 5-HT concentrations via LC-MS/MS. In addition, enteroids from each treatment also were fixed in 4% paraformaldehyde and embedded in paraffin for staining.

Human Intestinal Epithelial Cell Culture

To confirm the adherence of B dentium to intestinal mucus, the mucus-secreting human colon LS174T cells ATCC CL-188 were seeded at a density of 1 × 105 cells onto Corning Costar 24-well cell culture plates containing poly-D-lysine–coated coverslips. Confluent coverslips were inoculated with 2 × 105 viable B dentium cells, and then incubated anaerobically at 37°C for 1 hour. After the incubation period, the coverslips were washed thoroughly with PBS (3×) and processed for scanning electron microscopy.

Scanning Electron Microscopy

After incubation with bacteria, washed coverslips were fixed in 2.5% glutaraldehyde in PBS for 1 hour at room temperature. Alternatively, intestinal segments were opened lengthwise, thoroughly washed with PBS, and fixed in 2.5% glutaraldehyde in PBS for 4 hours at room temperature. Cells then were incubated with 1% osmium tetroxide in PBS (cat. 201030; Sigma-Aldrich) overnight at 4°C. Tissue and coverslips were dehydrated with ethanol (10 minutes each in 25%, 50%, 75%, 80%, 95%, and 4 cycles of 100%) at room temperature. In a desktop sputtering system (Denton Desk II), cells were coated with 20 nm of gold and viewed via scanning electron microscopy (FEI XL-30FEG) at 12 kV as previously described. Adobe Photoshop (San Jose, CA) was used to falsely color resulting images based on the morphology of bacterial cells.

Intestinal Tissue Staining

Immunofluorescence

Staining was performed on 7-μm, paraffin-embedded sections of mouse intestine or enteroids. After dehydration, slides were incubated in Antigen Unmasking Solution Citrate Buffer pH 6 (Vector Labs, Burlingame, CA) for 20 minutes at 100°C in a steamer for antigen retrieval, then blocked for 1 hour at room temperature in 10% donkey serum. Staining was performed with primary antibodies (Table 2) overnight at 4°C. Primary antibodies were recognized by the following secondary antibodies (Table 2) diluted at 1:1000 in PBS-tween (PBS-T) and incubated for 1 hour at room temperature. Nuclei were stained with Hoechst 33342 (Invitrogen) for 10 minutes at room temperature and all slides were cover-slipped with mounting media (Life Technologies) and imaged using a Nikon Eclipse 90i epifluorescence microscope (Nikon, Tokyo, Japan).
Table 2

Primary and Secondary Antibodies

TypeTargetSpeciesRecognizesCompanyCategoryDilution
PrimaryChgARabbitHumanNovus Biologicals, Littleton, CONBP2-531401:200
PrimaryChgARabbitMouseAbcam, Cambridge, MAab451791:200
Primary5-HTGoatMouse, humanImmunostar, Hudson, WI200791:100
Primary5-HTRatMouseSanta Cruzsc-580311:100
PrimarySERTRabbitMouse, humanImmunostar243301:5000
PrimaryFFAR2RabbitMouseMillipore, Burlington, MAABC2991:200
PrimaryCHATGoatMouse, humanMilliporeAB144P1:100
SecondaryAnti-goat Alexa Fluor 488DonkeyGoatLife TechnologiesA110551:1000
SecondaryAnti-goat Alexa Fluor 555DonkeyGoatLife TechnologiesA-214321:1000
SecondaryAnti-rabbit Alexa Fluor 488DonkeyRabbitLife TechnologiesR371161:1000
SecondaryAnti-rabbit Alexa Fluor 555DonkeyRabbitLife TechnologiesA315721:1000
Primary and Secondary Antibodies

Tissue Gram stain

To examine bacterial colonization within the mucus layer, Gram staining was performed on intestinal tissue sections. Briefly, paraffin-embedded tissue sections were dehydrated, and then incubated with crystal violet followed by gram iodine as a mordant. After exposure to a decolorizer, solvent sections were stained with gram safranin, followed by picric acid–acetone. After subsequent dehydration through a series of alcohols and xylene, sections were cover-slipped and imaged via brightfield microscopy.

Fluorescence in situ hybridization staining

Carnoy’s fixed, paraffin-embedded, mouse intestinal tissue sections (4-μm–thick sections) were mounted on glass slides. Briefly, sections were dehydrated in ethanol and incubated with the probe in a humidifying dark chamber at 45°C. The probe used was a previously validated, 5’ Texas Red–labeled Bifidobacterium genus–specific probe (Bif164; 5’-CATCCGGCATTACCACCC-3’) (Integrated DNA Technologies, Coralville, IA) targeted to the 164–181 bp region of 16S ribosomal RNA. The probe was hybridized to the samples by adding 15 μL of probe (2 μmol/L) to each slide and placing in a 45°C hybridization chamber for 45 minutes. Nuclei were labeled with 4′,6-diamidino-2-phenylindole. Images were acquired using a Nikon Eclipse 90i epifluorescence microscope as previously described.,,

Microscopy

Fluorescence and transmitted light images were taken on an upright Nikon Eclipse 90i microscope using Nikon Elements software for image acquisition and processing. The following objectives were used: 20× Plan Apochromat Objective (numerical aperture, 0.75) differential interference contrast objective and 40× Plan Apochromat Objective (numerical aperture, 0.95) differential interference contrast objective. Fluorescence images were recorded using a CoolSNAP HQ2 camera (Photometrics, Tucson, AZ) with a SPECTRA X LED light source (Lumencor, Beaverton, OR). Color images for H&E sections were recorded using a DS-Fi1-U2 camera (Nikon, Tokyo, Japan).

Quantitative Real-Time Polymerase Chain Reaction

To quantify relative messenger RNA (mRNA) expression of each gene of interest, total RNA was extracted from ileum and colon samples stored in TRIzol according to the manufacturer’s instructions. Complementary DNA (cDNA) was generated from 1 μg RNA via the SensiFAST cDNA synthesis kit (Bioline USA, Inc, Taunton, MA). Alternatively, genomic DNA was isolated from fecal extracts using the Zymo genomic DNA MiniPrep Kit (cat. 11-317C; Zymo Research, Irvine, CA) with the addition of bead beating. Quantitative real-time PCR (qPCR) was performed using a QuantStudio 3 (Applied Biosystems, Foster City, CA) qPCR machine. Forward and reverse primers specific for each gene (Table 3) were added to FastSYBR Green mastermix (Thermo-Fisher Scientific) and cDNA. Primers were obtained from ABI Primer 3 software, PrimerBank, or from previous literature.,61, 62, 63, 64 Target genes were normalized to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase and relative expression was calculated using the Delta-Delta-Ct (ddCT) method.
Table 3

Primers Used in This Study

GeneForward (5’) sequenceReverse (3’) sequenceReference
B dentiumATCCCGGGGGTTCGCCTGAAGGGCTTGCTCCCGAMatsuki
B ovatusAAGTCGAGGGGC AGCATT TTCACAACTGACTTAACAATCCMiyamoto
GAPDHCATGGCCTTCCGTGTTCCTACCTGCTTCACCACCTTCTTGAT61
CHGACCCACTGCAGCATCCAGTTAGTCCCGACTGACCATCATCTTTC25
TPH1AAGAAATTGGCCTGGCTTCGTTTGCACAGCCCAAACTC25
FFAR2ATCCTCCTGCTTAATCTGACCCCGCACACGATCTTTGGTAGGTPrimerbank
SERTTGGGCGCTCTACTACCTCATATGTTGTCCTGGGCGAAGTA60
Htr1aTACTGGGCAATCACCGACCCTATGAGATGAGAAAGCCAATGAGCCAAPrimer 3
Htr1bCCTGGTGATGCCTATCTGTAAGGAAGTTTGTGGAACGCTTGTTTGAAGTPrimer 3
Htr1dCCGAGAAAGGAAAGCCACTAAGACATACTACAAAGAAAGGCAACCAGCAPrimer 3
htr1fGACAACCACCATCAACTCCCTCAAATCTGTAACTGCCAAGGAACAAAPrimer 3
Htr2aACATCCAGGTAAATCCAGACGGATGTCACTTGCCATAGCTGAPrimer 3
Htr2cAGAAGGGTGATGAGGAAGAGAACGACACAAAGAATACAATGCCAAGGACTPrimer 3
Htr3aGCCACCCAGGAGGATACCACGCTCCCACTCGCCCTGATT64
Htr4TCGGCATAGTTGATGTGATAGAGAAAATGAGGAGAAACGGGATGTAGAAGGPrimer 3
Htr5aAAAGTCAGGACTAGCACTCGAAAGTCAGGACTAGCACTCG64
Htr5bCCCTTGATTTACACTGCCCAGAAATGGAGCACAATTCAC64
Htr6CTGATGGTGGGATTGGTGGTGATGGATGAGGCAGAGGTTGAGAATGGAGPrimer 3
Htr7TTCGAGACTGCTCAAACACTGCAGCAGAGAGCTTCCGGT64
Primers Used in This Study

Brain RNA In Situ Hybridization

Brains of adult germ-free and B dentium mono-associated mice (n = 5–6 per group) were dissected rapidly, cut along the sagittal midline, and placed in molds with tissue freezing media (O.C.T., TissueTek, Sakura, Torrance, CA) for frozen sectioning. RNA in situ hybridization (ISH) was performed on 25-μm–thick sagittal sections. Digoxigenin-labeled mRNA antisense probes were generated against htr2a using reverse-transcribed mouse cDNA as a template and a RNA digoxigenin-labeling kit from Roche (Basel, Switzerland). Primer sequences for the htr2a probe are as follows: forward: GCGATTTAGGTGACACTATAGCCTAATGACTTCAACTCCAGGG; reverse: GCGTAATACGACTCACTATAGGGCCACAAAAGAGCCTATGAGGAC. ISH was performed by the RNA in situ Hybridization Core at Baylor College of Medicine using an automated robotic platform. Quantitative analysis of the fluorescence in situ hybridization (FISH) signal on sections was performed using software developed for the core by Dr James Carson as previously described. Single-cell expression of htr2a within specific brain regions (manually defined in software) were categorized as weak, media, or strongly expressing based on the staining intensity for each region of the hippocampus separately. Four sagittal sections were analyzed per mouse, with 5–6 mice per treatment group.

Behavioral Testing: Marble Burying Test

This test was performed as previously described with slight modifications.66, 67, 68 Mice were removed from gnotobiotic isolators and allowed to acclimate to the testing room without being disturbed for 1 hour before testing. Lighting conditions and noise levels were kept constant across all tests. Clean transparent polycarbonate boxes (30 × 30 cm) were filled with a 5-cm layer of fresh, unscented, wood chip bedding. Twenty-five black glass marbles were placed lightly on top of the bedding, spaced equidistantly (5-cm apart) in a 5 × 5 arrangement. Animals (n = 12–13 mice per group) were placed gently in the corner of the testing cage and left undisturbed for 13 minutes, with the researcher out of the room. At the end of the test the mouse was removed promptly, with care taken to not disturb the marbles. The number of marbles buried during the test was recorded by 2 independent blinded observers. Marbles were considered buried when >60% was covered by bedding material. Scores from each observer for each mouse were averaged, and are presented as the percentage buried (number buried/total number of marbles in the cage). Marbles were rinsed in 70% ethanol, then in water, and dried before the next test. Bedding in the cage was flattened using a sterile cage bottom between tests. Cage bedding was changed between sexes and between groups of different colonization status.

Footprint Analysis

The commonly used footprint analysis was used to analyze motor coordination by assessing gait during normal walking., Briefly, hind paws were painted with blue ink and mice were encouraged to walk through a narrow, enclosed corridor in a straight line over paper by the presence of bedding, food, and darkness at the end of the tunnel. The footprint test was repeated until at least 2 clear sets of footprints were obtained per mouse (n = 5–7 mice/group). The distance was measured from the center of footpad for each metric (sway, stance, and stride) and was averaged from 2–3 runs per mouse.

Balance Beam

The balance beam test was used to detect subtle deficits in motor skills and balance., Each mouse was placed on a brightly lit platform and allowed to transverse a narrow beam to reach an enclosed safety box at the end of the beam. Mice were trained before tests with 3 successful training runs. The time to cross the beam was defined as 2 successful trials in which the mouse did not stall on the beam. The times to complete crossing the beam were recorded and averaged per mouse. This procedure was videorecorded to allow for finer analysis of paw slipping (n = 5–7 mice/group).

Statistical Analysis

Biostatistical analyses were performed using GraphPad Prism (version 6) software (GraphPad, Inc, La Jolla, CA). Comparisons were made with either 1-way or 2-way analysis of variance and the Bonferroni post hoc test. Nonparametric data were log-transformed to pass normality tests before analysis by analysis of variance. Differences between the groups were considered significant at P < .05 (∗) and the data are presented as means ± SEM.
  148 in total

Review 1.  Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role?

Authors:  Lakshminarayan M Iyer; L Aravind; Steven L Coon; David C Klein; Eugene V Koonin
Journal:  Trends Genet       Date:  2004-07       Impact factor: 11.639

2.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.

Authors:  William R Wikoff; Andrew T Anfora; Jun Liu; Peter G Schultz; Scott A Lesley; Eric C Peters; Gary Siuzdak
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

3.  Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.

Authors:  S Guglielmetti; D Mora; M Gschwender; K Popp
Journal:  Aliment Pharmacol Ther       Date:  2011-03-21       Impact factor: 8.171

4.  Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.

Authors:  M A Zocco; L Zileri dal Verme; F Cremonini; A C Piscaglia; E C Nista; M Candelli; M Novi; D Rigante; I A Cazzato; V Ojetti; A Armuzzi; G Gasbarrini; A Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2006-06-01       Impact factor: 8.171

5.  Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine.

Authors:  Shin-ichiro Karaki; Retsu Mitsui; Hisayoshi Hayashi; Ikuo Kato; Hiroshi Sugiya; Toshihiko Iwanaga; John B Furness; Atsukazu Kuwahara
Journal:  Cell Tissue Res       Date:  2006-02-01       Impact factor: 5.249

6.  Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.

Authors:  Jill M Hoffman; Karl Tyler; Sarah J MacEachern; Onesmo B Balemba; Anthony C Johnson; Elice M Brooks; Hong Zhao; Greg M Swain; Peter L Moses; James J Galligan; Keith A Sharkey; Beverley Greenwood-Van Meerveld; Gary M Mawe
Journal:  Gastroenterology       Date:  2012-01-04       Impact factor: 22.682

7.  Lactobacillus rhamnosus GG supernatant upregulates serotonin transporter expression in intestinal epithelial cells and mice intestinal tissues.

Authors:  Y M Wang; X Z Ge; W Q Wang; T Wang; H L Cao; B L Wang; B M Wang
Journal:  Neurogastroenterol Motil       Date:  2015-06-18       Impact factor: 3.598

8.  Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan.

Authors:  Maria Ringvall; Elin Rönnberg; Sara Wernersson; Annette Duelli; Frida Henningsson; Magnus Abrink; Gianni García-Faroldi; Ignacio Fajardo; Gunnar Pejler
Journal:  J Allergy Clin Immunol       Date:  2008-01-30       Impact factor: 10.793

9.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

10.  Bifidobacterium breve reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner.

Authors:  K R Hughes; L C Harnisch; C Alcon-Giner; S Mitra; C J Wright; J Ketskemety; D van Sinderen; A J M Watson; L J Hall
Journal:  Open Biol       Date:  2017-01       Impact factor: 6.411

View more
  19 in total

Review 1.  Enterochromaffin Cells-Gut Microbiota Crosstalk: Underpinning the Symptoms, Pathogenesis, and Pharmacotherapy in Disorders of Gut-Brain Interaction.

Authors:  Lai Wei; Rajan Singh; Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2022-06-20       Impact factor: 4.725

2.  Genome-wide siRNA screening reveals several host receptors for the binding of human gut commensal Bifidobacterium bifidum.

Authors:  Veera Kainulainen; Carina von Schantz-Fant; Ruusu-Maria Kovanen; Swapnil Potdar; Karoliina Laamanen; Jani Saarela; Reetta Satokari
Journal:  NPJ Biofilms Microbiomes       Date:  2022-06-29       Impact factor: 8.462

Review 3.  Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems.

Authors:  Theresa B Legan; Brigitte Lavoie; Gary M Mawe
Journal:  Neurogastroenterol Motil       Date:  2022-03-05       Impact factor: 3.960

4.  The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal.

Authors:  Melinda A Engevik; Heather A Danhof; Anne Hall; Kristen A Engevik; Thomas D Horvath; Sigmund J Haidacher; Kathleen M Hoch; Bradley T Endres; Meghna Bajaj; Kevin W Garey; Robert A Britton; Jennifer K Spinler; Anthony M Haag; James Versalovic
Journal:  BMC Microbiol       Date:  2021-05-24       Impact factor: 3.605

Review 5.  Diet-induced dysbiosis of the maternal gut microbiome in early life programming of neurodevelopmental disorders.

Authors:  Claudia M Di Gesù; Lisa M Matz; Shelly A Buffington
Journal:  Neurosci Res       Date:  2021-05-13       Impact factor: 2.904

Review 6.  The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

Authors:  Seppo Salminen; Maria Carmen Collado; Akihito Endo; Colin Hill; Sarah Lebeer; Eamonn M M Quigley; Mary Ellen Sanders; Raanan Shamir; Jonathan R Swann; Hania Szajewska; Gabriel Vinderola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-04       Impact factor: 73.082

Review 7.  Maternal and early life exposures and their potential to influence development of the microbiome.

Authors:  Erin E Bolte; David Moorshead; Kjersti M Aagaard
Journal:  Genome Med       Date:  2022-01-11       Impact factor: 15.266

Review 8.  Citrobacter rodentium infection at the gut-brain axis interface.

Authors:  Fernando H Martins; Santiago Cuesta
Journal:  Curr Opin Microbiol       Date:  2021-07-01       Impact factor: 7.584

Review 9.  Mango (Mangifera indica L.) Polyphenols: Anti-Inflammatory Intestinal Microbial Health Benefits, and Associated Mechanisms of Actions.

Authors:  Hyemee Kim; Maria Joselyn Castellon-Chicas; Shirley Arbizu; Stephen T Talcott; Nicholas L Drury; Shayna Smith; Susanne U Mertens-Talcott
Journal:  Molecules       Date:  2021-05-06       Impact factor: 4.411

Review 10.  Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications.

Authors:  Miguel A Ortega; Miguel Angel Alvarez-Mon; Cielo García-Montero; Oscar Fraile-Martinez; Luis G Guijarro; Guillermo Lahera; Jorge Monserrat; Paula Valls; Fernando Mora; Roberto Rodríguez-Jiménez; Javier Quintero; Melchor Álvarez-Mon
Journal:  Metabolites       Date:  2022-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.